Jene-35 ED is a medicine containing the active ingredient(s) cyproterone + ethinylestradiol. On this page you will find out more about Jene-35 ED, including side effects, age restrictions, food interactions and whether the medicine is subsidised by the government on the pharmaceutical benefits scheme (PBS)
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional. Always read the label. If symptoms persist see your healthcare professional. healthdirect medicines information is not intended for use in an emergency. If you are suffering an acute illness, overdose, or emergency condition, call triple zero (000) and ask for an ambulance.
Reasonable care has been taken to provide accurate information at the time of creation. This information is not intended to substitute medical advice, diagnosis or treatment and should not be exclusively relied on to manage or diagnose a medical condition. Please refer to our terms and conditions.
Active ingredient in this medicine: cyproterone + ethinylestradiol
Information for medicine and pack size:
Jene-35 ED (21 x 2 mg/35 microgram tablets, 7 x inert tablets), 28
Consumer Medicine Information leaflet:
This leaflet may also be found inside the medicine package. It contains information on side effects, age restrictions and other useful data.
What this medicine is for
Indicated for the treatment of signs of androgenisation in women such as severe acne (involving inflammation or nordularity or risk of scarring) where prolonged oral antibiotics or local treatment alone has not been successful, or idiopathic hirsutism of mild to moderate degree. Jene-35ED will also provide effective oral contraception in this patient group. If the hirsutism has only recently appeared or has lately intensified to a considerable extent, the cause (androgen-producing tumour or an adrenal enzyme defect) must be clarified by differential diagnosis.
Table of characteristics
28 tablets (1 Blister pack contains 1x 21 yellow active tablets and 1x7 white placebo tablets): Prescription Only Medicine, or Prescription Animal Remedy
28 tablets x 3 (3x 21 yellow active tablets and 3x7 white placebo tablets): Prescription Only Medicine, or Prescription Animal Remedy
|Visual appearance||White, round, biconvex tablet, plain on both surfaces.|
|Route of administration||Oral|
|Visual appearance||A yellowish buff, round, biconvex tablet, plain on both faces.|
|Dosage Form||Tablet, film coated|
|Route of administration||Oral|
There is one type of pack available.
Pack type 1
|Storage temperature||Store below 30 degrees Celsius|
|Storage conditions||Protect from Light,Protect from Moisture|
|Life time||3 Years|
We were unable to verify that this medicine is available on the PBS (Pharmaceutical Benefits Scheme). Please consult your pharmacist if you need further information
The PBS provides a list of government subsidised medicines available to be dispensed to patients. Further information can be found on the Pharmaceutical Benefits Scheme website.
Is this medication banned in sport?
Check if you can use your medicine whilst playing sport. Search the Australian Sports Anti-Doping Authority (ASADA) database that provides information about the prohibited status of specific medications and/or the active ingredient based on the current World Anti-Doping Agency (WADA) Prohibited List.